Brief: 4Dmt Appoints Uneek Mehra As Chief Financial And Business Officer
4D Molecular Therapeutics Inc FDMT.O :
* 4DMT APPOINTS UNEEK MEHRA AS CHIEF FINANCIAL AND BUSINESS
OFFICER
* 4D MOLECULAR THERAPEUTICS INC - APPOINTMENT OF UNEEK MEHRA
AS
CHIEF FINANCIAL & BUSINESS OFFICER OF 4DMT
* 4D MOLECULAR THERAPEUTICS INC - MEHRA WILL SUCCEED AUGUST
J.
MORETTI, J.D., WHO IS RETIRING, AND HAS AGREED TO SERVE IN AN
ADVISORY CAPACITY
Source text for Eikon: ID:nGNX3fYzMw
Further company coverage: FDMT.O
Recent news on 4D Molecular Therapeutics
See all news4D Molecular Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
4D Molecular Therapeutics Q2 net loss widens
Brief: 4D Molecular Therapeutics Q2 Net Income USD -72.936 Million Vs. IBES Estimate USD -70.3 Million
4D Molecular Therapeutics Inc expected to post a loss of $1.02 a share - Earnings Preview
Brief: 4d Molecular Therapeutics Says 4D-150 Continues To Be Well Tolerated With No New Safety Findings